©The Author(s) 2023.
World J Gastrointest Surg. Jul 27, 2023; 15(7): 1375-1387
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1375
Published online Jul 27, 2023. doi: 10.4240/wjgs.v15.i7.1375
Table 1 Clinical features of patients in two groups
| Characteristic | Total cohort, n = 347 | Training cohort, n = 243 | Validation cohort, n = 104 |
| Age, yr | |||
| < 73 | 233 (67.1%) | 75 (72.1%) | 158 (65.0%) |
| ≥ 73 | 114 (32.9%) | 85 (35.0%) | 29 (27.9%) |
| Sex | |||
| Female | 89 (25.6%) | 60 (24.7%) | 29 (27.9%) |
| Male | 258 (74.4%) | 183 (75.3%) | 75 (72.1%) |
| Tumor size, cm | |||
| < 3.5 | 93 (26.8%) | 64 (26.3%) | 29 (27.9%) |
| ≥ 3.5 | 254 (73.2%) | 179 (73.7%) | 75 (72.1%) |
| Stage | |||
| I | 61 (17.6%) | 42 (17.3%) | 19 (18.3%) |
| II | 83 (23.9%) | 61 (25.1%) | 22 (21.1%) |
| III | 181 (52.1%) | 125 (51.4%) | 56 (53.8%) |
| IV | 24 (6.3%) | 15 (6.2%) | 7 (6.7%) |
| Liver metastasis | |||
| No | 326 (94.0%) | 227 (93.4%) | 99 (95.2%) |
| Yes | 21 (6.0%) | 16 (6.6%) | 5 (4.8%) |
| Lymphocyte count, × 109/L | |||
| < 1.2 | 134 (38.6%) | 101 (41.6%) | 33 (31.7%) |
| ≥ 1.2 | 213 (61.4%) | 142 (58.4%) | 71 (68.3%) |
| AFP, ng/mL | |||
| < 2.6 | 205 (59.1%) | 143 (58.8%) | 62 (59.6%) |
| ≥ 2.6 | 142 (40.9%) | 100 (41.2%) | 42 (43.1%) |
| Type of surgery | |||
| Partial excision | 191 (55.0%) | 130 (53.4%) | 61 (58.7%) |
| Total gastrectomy | 156 (45.0%) | 113 (46.6%) | 43 (41.3%) |
| GC type | |||
| Ulcer type | 289 (83.3%) | 207 (85.1%) | 82 (78.8%) |
| Polyp type | 26 (7.5%) | 16 (6.6%) | 10 (9.6%) |
| Diffuse type | 11 (3.2%) | 8 (3.3%) | 3 (2.9%) |
| Others | 21 (6.0%) | 12 (5.0%) | 9 (8.7%) |
| Peritoneal metastasis | |||
| No | 322 (92.8%) | 226 (93.1%) | 96 (92.3%) |
| Yes | 25 (7.2%) | 17 (6.9%) | 8 (7.7%) |
| Lymphatic metastasis | |||
| No | 95 (27.4%) | 64 (26.6%) | 31 (29.8%) |
| Yes | 252 (72.6%) | 179 (73.4%) | 73 (70.2%) |
| Remote metastasis | |||
| No | 323 (93.1%) | 228 (93.8%) | 95 (91.3%) |
| Yes | 24 (6.9%) | 15 (6.2%) | 9 (8.9%) |
| Vascular invasion | |||
| No | 195 (56.2%) | 136 (66.0%) | 59 (56.7%) |
| Yes | 152 (43.8%) | 107 (44.0%) | 45 (43.3%) |
| Histological differentiation | |||
| Highly or moderately differentiated | 98 (28.2%) | 70 (28.85) | 28 (26.9%) |
| Lowly or undifferentiated | 222 (64.0%) | 155 (63.8%) | 67 (64.4%) |
| Indolent cell or mucinous adenocarcinoma | |||
| Monocyte count, × 109/L | 27 (7.8%) | 18 (7.4%) | 9 (8.7%) |
| < 0.47 | |||
| ≥ 0.47 | 172 (49.6%) | 101 (41.6%) | 71 (68.3%) |
| Red cell distribution width, % | 175 (50.4%) | 142 (58.4%) | 33 (31.7%) |
| < 18.9 | 307 (88.5%) | 216 (88.9%) | 91 (87.5%) |
| ≥ 18.9 | 40 (11.5%) | 27 (11.1%) | 13 (12.5%) |
| Red blood cell specific volume, L/L | |||
| < 0.34 | 266 (76.7%) | 192 (79.0%) | 74 (71.2%) |
| ≥ 0.34 | 81 (23.3%) | 51 (21.0%) | 30 (28.8%) |
| Mean corpuscular hemoglobin, pg | |||
| < 30.70 | 297 (85.6%) | 211 (86.8%) | 86 (82.7%) |
| ≥ 30.70 | 50 (14.4%) | 32 (13.2%) | 18 (17.3%) |
| Mean corpuscular volume, fL | |||
| < 87.30 | 187 (53.9%) | 134 (55.1%) | 53 (51.0%) |
| ≥ 87.30 | 160 (46.1%) | 109 (44.9%) | 51 (49.0%) |
- Citation: Long Y, Zhou XL, Zhang CL, Wang YN, Pan WS. Nomogram based on clinical characteristics for predicting overall survival in gastric cancer patients with preoperative anemia. World J Gastrointest Surg 2023; 15(7): 1375-1387
- URL: https://www.wjgnet.com/1948-9366/full/v15/i7/1375.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i7.1375